UHealth - University of Miami Health System

UHealth News

UHealth - University of Miami Health System

New MS drug Gilenya Approved for First-Line Therapy

January 26, 2011

Kottil Rammohan, M.D., professor of neurology and director of the Multiple Sclerosis Center at the University of Miami Miller School of Medicine, discusses Gilenya (fingolimod), a new drug approved by the FDA as a first-line therapy for multiple sclerosis. Dr. Rammohan addresses the efficacy of the drug and whether cost will limit the usage to second-line therapy.

Watch Dr. Rammohan discuss Gilenya »

UHealth - University of Miami Health System

Current guidelines and methods for treating knee and head injuries in NCAA athletes

January 01, 2011

Lee Kaplan, MD, Chief of Sports medicine at The University of Miami Health System and team doctor for the Miami Hurricanes football team discusses the state-of-the-art methods for surgically repairing torn knee meniscus injuries and for repairing torn ACL’s. Clifton Page, MD, internists for the Miami Hurricanes football team, discusses the new guidelines for handling the return to play for athletes who have suffered a concussion, testing for sickle cell, and for monitoring heat exhaustion.

E-mail a Friend

MyUHealthChart.com

Connect with doctors & view medical records

UHealthAware

Free on-line health risk assessments that may save your life.